CN105467052A - 参乌益肾片成分检测方法及指纹图谱构建方法 - Google Patents
参乌益肾片成分检测方法及指纹图谱构建方法 Download PDFInfo
- Publication number
- CN105467052A CN105467052A CN201510795368.6A CN201510795368A CN105467052A CN 105467052 A CN105467052 A CN 105467052A CN 201510795368 A CN201510795368 A CN 201510795368A CN 105467052 A CN105467052 A CN 105467052A
- Authority
- CN
- China
- Prior art keywords
- acetonitrile
- kidney
- ginseng
- detection method
- chromatographic column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 96
- 239000000243 solution Substances 0.000 claims abstract description 39
- 238000001514 detection method Methods 0.000 claims abstract description 38
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 33
- 239000012086 standard solution Substances 0.000 claims abstract description 19
- 239000011260 aqueous acid Substances 0.000 claims abstract description 13
- 238000012360 testing method Methods 0.000 claims description 45
- 241000208340 Araliaceae Species 0.000 claims description 36
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 36
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 36
- 235000008434 ginseng Nutrition 0.000 claims description 36
- QQUHMASGPODSIW-UHFFFAOYSA-N Albiflorin Natural products C=1C=CC=CC=1C(=O)OCC12C(=O)OC3(C)CC(O)C1CC32OC1OC(CO)C(O)C(O)C1O QQUHMASGPODSIW-UHFFFAOYSA-N 0.000 claims description 29
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 claims description 29
- QQUHMASGPODSIW-ICECTASOSA-N albiflorin Chemical compound O([C@@]12C[C@H]3[C@H](O)C[C@@]1(OC(=O)[C@]32COC(=O)C=1C=CC=CC=1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QQUHMASGPODSIW-ICECTASOSA-N 0.000 claims description 29
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 claims description 29
- 238000002360 preparation method Methods 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 16
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 14
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 14
- 238000005304 joining Methods 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 10
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 238000010276 construction Methods 0.000 claims description 8
- 238000002137 ultrasound extraction Methods 0.000 claims description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 5
- 229960000583 acetic acid Drugs 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 235000019253 formic acid Nutrition 0.000 claims description 5
- 239000012362 glacial acetic acid Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 23
- 239000013558 reference substance Substances 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 240000001341 Reynoutria japonica Species 0.000 description 11
- 235000018167 Reynoutria japonica Nutrition 0.000 description 11
- 229940079593 drug Drugs 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 7
- 241000110637 Cuscuta chinensis Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 235000003805 Musa ABB Group Nutrition 0.000 description 4
- 240000008790 Musa x paradisiaca Species 0.000 description 4
- 235000015266 Plantago major Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- JAYVHSBYKLLDJC-DSNJPTTOSA-N (E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C=C(O)C=C1\C=C\C1=CC=C(O)C=C1 JAYVHSBYKLLDJC-DSNJPTTOSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- -1 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-Glucose glycosides Chemical class 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000012113 quantitative test Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 206010037601 Pyelonephritis chronic Diseases 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000009045 body homeostasis Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- 201000006368 chronic pyelonephritis Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000022182 gross hematuria Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 210000000885 nephron Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012536 packaging technology Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicines Containing Plant Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510795368.6A CN105467052B (zh) | 2015-11-18 | 2015-11-18 | 参乌益肾片成分检测方法及指纹图谱构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510795368.6A CN105467052B (zh) | 2015-11-18 | 2015-11-18 | 参乌益肾片成分检测方法及指纹图谱构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105467052A true CN105467052A (zh) | 2016-04-06 |
CN105467052B CN105467052B (zh) | 2017-03-29 |
Family
ID=55604978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510795368.6A Active CN105467052B (zh) | 2015-11-18 | 2015-11-18 | 参乌益肾片成分检测方法及指纹图谱构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105467052B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1751718A (zh) * | 2005-07-22 | 2006-03-29 | 陈然 | 一种中药组合物及其制备方法和质量控制方法 |
CN104849364A (zh) * | 2015-05-05 | 2015-08-19 | 山东大学 | 参枝苓口服液指纹图谱的建立方法及其指纹图谱与应用 |
CN104849384A (zh) * | 2015-04-17 | 2015-08-19 | 武汉康乐药业股份有限公司 | 建立健肝乐制剂指纹图谱的方法及其应用 |
-
2015
- 2015-11-18 CN CN201510795368.6A patent/CN105467052B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1751718A (zh) * | 2005-07-22 | 2006-03-29 | 陈然 | 一种中药组合物及其制备方法和质量控制方法 |
CN104849384A (zh) * | 2015-04-17 | 2015-08-19 | 武汉康乐药业股份有限公司 | 建立健肝乐制剂指纹图谱的方法及其应用 |
CN104849364A (zh) * | 2015-05-05 | 2015-08-19 | 山东大学 | 参枝苓口服液指纹图谱的建立方法及其指纹图谱与应用 |
Non-Patent Citations (5)
Title |
---|
MAN LIU 等: "Quality Evaluation of a Herbal Prescription Through Quantification of 40 Components by HPLC–ESI–MS/MS", 《PHYTOCHEMICAL ANALYSIS》 * |
傅予 等: "HPLC 法测定养血生发胶囊中5种活性成分", 《现代药物与临床》 * |
葛志伟 等: "RP-HPLC法测定杭白芍及其饮片中芍药内酯苷、芍药苷和苯甲酰芍药苷", 《中草药》 * |
谢东 等: "HPLC法测定复方参乌口服液中大黄素的含量", 《中国现代应用药学杂志》 * |
陈思 等: "清毒安肾胶囊高效液相色谱指纹图谱质量控制方法研究", 《中南药学》 * |
Also Published As
Publication number | Publication date |
---|---|
CN105467052B (zh) | 2017-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103926351B (zh) | 生血宝制剂质量检测方法及其标准指纹图谱的构建方法 | |
CN103207255B (zh) | 一种脑心通胶囊的含量检测方法 | |
CN107727753B (zh) | 百乐眠胶囊指纹图谱的建立方法 | |
CN103808835B (zh) | Hplc-dad法同时测定四物汤煎剂中10种化学成分含量的方法 | |
CN106053700B (zh) | 一种首乌益智胶囊的指纹图谱测定方法 | |
CN107860832A (zh) | 复方大黄清胰汤指纹图谱的建立方法 | |
CN105353063B (zh) | 复方感冒灵流膏化学成分标准指纹图谱及构建方法、应用 | |
CN105301136B (zh) | 一种九味熄风颗粒成分定量检测方法及其指纹图谱构建方法 | |
CN106404942A (zh) | 一种康肾颗粒指纹图谱的构建方法及其标准指纹图谱 | |
CN106053702B (zh) | 一种加味逍遥丸的多成分含量测定方法 | |
CN102539599B (zh) | 一种强肝药物的检测方法 | |
CN104155383B (zh) | 青蒲颗粒的检测方法 | |
CN104965033B (zh) | 一种苍柏袪痛制剂hplc指纹图谱的测定方法 | |
CN106290599A (zh) | 一种中药组合物的含量测定方法 | |
CN113281439B (zh) | 肾宝片的质量控制检测方法 | |
CN105911192A (zh) | 一种半枫荷活血化瘀活性部位的提取方法及指纹图谱检测方法 | |
CN104007198B (zh) | 一种灵芝皇制剂hplc标准指纹图谱及其构建方法和应用 | |
CN105424833A (zh) | 一种fkⅳ号颗粒成分检测方法 | |
CN106918673B (zh) | 一种中药组合物的指纹图谱的建立方法 | |
CN104614475A (zh) | 一种消渴清颗粒的含量检测方法 | |
CN103575823B (zh) | 一种糖敏灵制剂中8种化学成分的检测方法 | |
CN113759056B (zh) | 一种半边莲及其制剂的特征图谱及其构建方法 | |
CN102008541B (zh) | 无糖型复方扶芳藤制剂中3种主要活性成分的同时检测方法 | |
CN105467052A (zh) | 参乌益肾片成分检测方法及指纹图谱构建方法 | |
CN104458954B (zh) | 一种菟丝子配方颗粒指纹图谱及其建立方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190328 Address after: 222001 Jiangning Industrial City, Lianyungang Economic and Technological Development Zone, Jiangsu Province Co-patentee after: JIANGSU KANION YANGGUANG PHARMACEUTICAL CO., LTD. Patentee after: Kangyuan Pharmceutical Co., Ltd. Address before: 222047 Jiangsu Lianyungang Economic and Technological Development Zone Jiangning Industrial City Jiangsu Kangyuan Pharmaceutical Co., Ltd. Patentee before: Kangyuan Pharmceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 210046, No. 29, Heng Jing Road, Nanjing economic and Technological Development Zone, Nanjing, Jiangsu Patentee after: JIANGSU KANION SUNSHINE PHARMACEUTICAL CO.,LTD. Patentee after: Jiangsu Kangyuan Pharmaceutical Co., Ltd Address before: 222001 Jiangning Industrial City, Lianyungang Economic and Technological Development Zone, Jiangsu Province Patentee before: JIANGSU KANION PHARMACEUTICAL Co.,Ltd. Patentee before: Jiangsu Kangyuan sunshine Pharmaceutical Co., Ltd |